Skip to main content
Top
Published in: International Orthopaedics 10/2017

01-10-2017 | Original Paper

The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial

Authors: Yiting Lei, Jinwei Xie, Bin Xu, Xiaowei Xie, Qiang Huang, Fuxing Pei

Published in: International Orthopaedics | Issue 10/2017

Login to get access

Abstract

Purpose

To assess the efficacy and safety of multiple-dose intravenous tranexamic acid (IV-TXA) on blood loss following total knee arthroplasty (TKA).

Methods

One hundred fifty nine patients received one bolus of IV-TXA before skin incision and two boluses three and six hours later (group A), or another bolus nine hours later (group B), or another two boluses nine and 12 hours later (group C). The primary outcomes were total blood loss (TBL), hidden blood loss (HBL), and maximum haemoglobin (Hb) drop. Other outcome measurements such as fibrinolysis parameters [fibrin(−ogen) degradation products (FDP), D-dimer], inflammatory factors [interleukin-6 (IL-6)], transfusion rate, range of motion (ROM), length of hospital stay (LOH), and complications were also recorded and compared.

Results

The mean TBL, HBL and maximum Hb drop in group C (p < 0.001, p < 0.001, p = 0.025) and group B (p = 0.025, p = 0.025, p = 0.044) were lower than those in group A. FDP and D-Dimer in group C was lower than in group A and B on post-operative day one. IL-6 in group A, B and C showed a downward tendency on post-operative days one and three (POD1 and POD3). Moreover, the ROM and LOH were better in group C. No episodes of transfusion or deep venous thrombosis (DVT) were detected in all groups.

Conclusions

The 5-dose TXA regimen can further reduce the blood loss, diminish the maximum Hb drop, minimize inflammation, enhance mobility, and shorten LOS following TKA, without increasing the risk of complications. An additional dose could be requisite when fibrinolysis maintains after 5-dose regimen has already been performed.
Level of evidence: I.
Literature
1.
go back to reference Xie J, Ma J, Yao H, Yue C, Pei F (2016) Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial. J Arthroplast. doi:10.1016/j.arth.2016.04.034 Xie J, Ma J, Yao H, Yue C, Pei F (2016) Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial. J Arthroplast. doi:10.​1016/​j.​arth.​2016.​04.​034
2.
3.
4.
go back to reference Rineau E, Chaudet A, Chassier C, Bizot P, Lasocki S (2016) Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before-after study. Transfusion 56(3):673–681. doi:10.1111/trf.13468 CrossRefPubMed Rineau E, Chaudet A, Chassier C, Bizot P, Lasocki S (2016) Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before-after study. Transfusion 56(3):673–681. doi:10.​1111/​trf.​13468 CrossRefPubMed
5.
8.
go back to reference Akgul T, Buget M, Salduz A, Edipoglu IS, Ekinci M, Kucukay S, Sen C (2016) Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: a prospective clinical study. Acta Orthop Traumatol Turc. doi:10.1016/j.aott.2016.06.007 Akgul T, Buget M, Salduz A, Edipoglu IS, Ekinci M, Kucukay S, Sen C (2016) Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: a prospective clinical study. Acta Orthop Traumatol Turc. doi:10.​1016/​j.​aott.​2016.​06.​007
9.
go back to reference Hourlier H, Reina N, Fennema P (2015) Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomised clinical trial. Arch Orthop Trauma Surg 135(4):465–471. doi:10.1007/s00402-015-2168-z CrossRefPubMed Hourlier H, Reina N, Fennema P (2015) Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomised clinical trial. Arch Orthop Trauma Surg 135(4):465–471. doi:10.​1007/​s00402-015-2168-z CrossRefPubMed
11.
go back to reference Huang Z, Ma J, Shen B, Pei F (2014) Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplast 29(12):2342–2346. doi:10.1016/j.arth.2014.05.026 CrossRef Huang Z, Ma J, Shen B, Pei F (2014) Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplast 29(12):2342–2346. doi:10.​1016/​j.​arth.​2014.​05.​026 CrossRef
13.
go back to reference Serrano Mateo L, Goudarz Mehdikhani K, Caceres L, Lee YY, Gonzalez Della Valle A (2016) Topical tranexamic acid may improve early functional outcomes of primary total knee arthroplasty. J Arthroplast 31(7):1449–1452. doi:10.1016/j.arth.2016.01.009 CrossRef Serrano Mateo L, Goudarz Mehdikhani K, Caceres L, Lee YY, Gonzalez Della Valle A (2016) Topical tranexamic acid may improve early functional outcomes of primary total knee arthroplasty. J Arthroplast 31(7):1449–1452. doi:10.​1016/​j.​arth.​2016.​01.​009 CrossRef
19.
go back to reference Morais S, Ortega-Andreu M, Rodriguez-Merchan EC, Padilla-Eguiluz NG, Perez-Chrzanowska H, Figueredo-Zalve R, Gomez-Barrena E (2014) Blood transfusion after primary total knee arthroplasty can be significantly minimised through a multimodal blood-loss prevention approach. Int Orthop 38(2):347–354. doi:10.1007/s00264-013-2188-7 CrossRefPubMed Morais S, Ortega-Andreu M, Rodriguez-Merchan EC, Padilla-Eguiluz NG, Perez-Chrzanowska H, Figueredo-Zalve R, Gomez-Barrena E (2014) Blood transfusion after primary total knee arthroplasty can be significantly minimised through a multimodal blood-loss prevention approach. Int Orthop 38(2):347–354. doi:10.​1007/​s00264-013-2188-7 CrossRefPubMed
20.
go back to reference Jimenez JJ, Iribarren JL, Brouard M, Hernandez D, Palmero S, Jimenez A, Lorente L, Machado P, Borreguero JM, Raya JM, Martin B, Perez R, Martinez R, Mora ML (2011) Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg 6:138. doi:10.1186/1749-8090-6-138 CrossRefPubMedPubMedCentral Jimenez JJ, Iribarren JL, Brouard M, Hernandez D, Palmero S, Jimenez A, Lorente L, Machado P, Borreguero JM, Raya JM, Martin B, Perez R, Martinez R, Mora ML (2011) Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg 6:138. doi:10.​1186/​1749-8090-6-138 CrossRefPubMedPubMedCentral
21.
go back to reference Robson SC, Shephard EG, Kirsch RE (1994) Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86(2):322–326CrossRefPubMed Robson SC, Shephard EG, Kirsch RE (1994) Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86(2):322–326CrossRefPubMed
22.
go back to reference Bergin PF, Doppelt JD, Kephart CJ, Benke MT, Graeter JH, Holmes AS, Haleem-Smith H, Tuan RS, Unger AS (2011) Comparison of minimally invasive direct anterior versus posterior total hip arthroplasty based on inflammation and muscle damage markers. J Bone Joint Surg Am 93(15):1392–1398. doi:10.2106/jbjs.j.00557 CrossRefPubMedPubMedCentral Bergin PF, Doppelt JD, Kephart CJ, Benke MT, Graeter JH, Holmes AS, Haleem-Smith H, Tuan RS, Unger AS (2011) Comparison of minimally invasive direct anterior versus posterior total hip arthroplasty based on inflammation and muscle damage markers. J Bone Joint Surg Am 93(15):1392–1398. doi:10.​2106/​jbjs.​j.​00557 CrossRefPubMedPubMedCentral
24.
go back to reference Xie J, Ma J, Kang P, Zhou Z, Shen B, Yang J, Pei F (2015) Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases. Thromb Res 136(2):234–238. doi:10.1016/j.thromres.2015.05.014 CrossRefPubMed Xie J, Ma J, Kang P, Zhou Z, Shen B, Yang J, Pei F (2015) Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases. Thromb Res 136(2):234–238. doi:10.​1016/​j.​thromres.​2015.​05.​014 CrossRefPubMed
25.
go back to reference Fillingham YA, Kayupov E, Plummer DR, Moric M, Gerlinger TL, Della Valle CJ (2016) The James A. Rand young investigator’s award: a randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost? J Arthroplast 31(9 Suppl):26–30. doi:10.1016/j.arth.2016.02.081 CrossRef Fillingham YA, Kayupov E, Plummer DR, Moric M, Gerlinger TL, Della Valle CJ (2016) The James A. Rand young investigator’s award: a randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost? J Arthroplast 31(9 Suppl):26–30. doi:10.​1016/​j.​arth.​2016.​02.​081 CrossRef
26.
go back to reference Wasko MK, Bobecka-Wesolowska K, Tomasiuk R, Kowalczewski J (2015) Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty. Clin Chem Lab Med 53(11):1785–1792. doi:10.1515/cclm-2014-1055 CrossRefPubMed Wasko MK, Bobecka-Wesolowska K, Tomasiuk R, Kowalczewski J (2015) Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty. Clin Chem Lab Med 53(11):1785–1792. doi:10.​1515/​cclm-2014-1055 CrossRefPubMed
Metadata
Title
The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial
Authors
Yiting Lei
Jinwei Xie
Bin Xu
Xiaowei Xie
Qiang Huang
Fuxing Pei
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
International Orthopaedics / Issue 10/2017
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-017-3519-x

Other articles of this Issue 10/2017

International Orthopaedics 10/2017 Go to the issue